TR199903192T2 - Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar. - Google Patents

Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.

Info

Publication number
TR199903192T2
TR199903192T2 TR1999/03192T TR9903192T TR199903192T2 TR 199903192 T2 TR199903192 T2 TR 199903192T2 TR 1999/03192 T TR1999/03192 T TR 1999/03192T TR 9903192 T TR9903192 T TR 9903192T TR 199903192 T2 TR199903192 T2 TR 199903192T2
Authority
TR
Turkey
Prior art keywords
preparations containing
erythropoietin
modified hemoglobin
combined preparations
containing erythropoietin
Prior art date
Application number
TR1999/03192T
Other languages
English (en)
Turkish (tr)
Inventor
Lehmann Paul
Town Michael-Harold
Feurstein Jurgen
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of TR199903192T2 publication Critical patent/TR199903192T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1999/03192T 1997-06-21 1998-06-03 Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar. TR199903192T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97110168A EP0885613A1 (de) 1997-06-21 1997-06-21 Verwendung von modifizierten Hämoglobinen zur Behandlung von Anämien und Kombinationspräparate umfassend Erythropoietin und modifiziertes Hämoglobin

Publications (1)

Publication Number Publication Date
TR199903192T2 true TR199903192T2 (xx) 2000-05-22

Family

ID=8226937

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/03192T TR199903192T2 (xx) 1997-06-21 1998-06-03 Eritropoetin, de�i�tirilmi� hemoglobin i�eren farmasotik kombine m�stahzarlar.

Country Status (15)

Country Link
US (3) US6440932B1 (enExample)
EP (2) EP0885613A1 (enExample)
JP (3) JP2002504913A (enExample)
KR (1) KR100519904B1 (enExample)
CN (1) CN1185010C (enExample)
AT (1) ATE272405T1 (enExample)
AU (1) AU743475B2 (enExample)
BR (1) BR9810267A (enExample)
CA (1) CA2294448C (enExample)
DE (1) DE59811768D1 (enExample)
DK (1) DK0996462T3 (enExample)
ES (1) ES2226151T3 (enExample)
PT (1) PT996462E (enExample)
TR (1) TR199903192T2 (enExample)
WO (1) WO1998058660A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998041226A1 (de) * 1997-03-18 1998-09-24 Roche Diagnostics Gmbh Pharmazeutische kombinationspräparate enthaltend erythropoietin und eisenpräparate
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
MEP90708A (hr) * 2000-05-15 2011-12-20 Nova farmaceutska smješa
AU3323002A (en) 2000-12-20 2002-07-01 Hoffmann La Roche Erythropoietin conjugates
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
CN1897959A (zh) 2003-09-29 2007-01-17 沃伦药品公司 用于治疗和预防脓毒病和粘连形成的组织保护细胞因子
RU2273485C2 (ru) * 2004-05-19 2006-04-10 Виктор Николаевич Алейников Железосодержащий препарат "феррал"
US7772182B2 (en) * 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
CN101534847A (zh) 2006-08-04 2009-09-16 普罗龙药品公司 修饰型促红细胞生成素
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
CL2008002054A1 (es) * 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
SMT202000649T1 (it) 2015-11-23 2021-01-05 Bristol Myers Squibb Co Sistemi di additivi per l'uso nella pegilazione di proteine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77081A (en) 1984-12-04 1999-10-28 Genetics Inst Dna sequence encoding human erythropoietin process for the preparation thereof and a pharmaceutical composition of human erythropoietin
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
JP2858752B2 (ja) * 1987-04-10 1999-02-17 オーソ・フアーマシユーチカル・コーポレーシヨン 正常な哺乳動物のヘマトクリツト値の増大方法
JPH03112934A (ja) * 1989-09-27 1991-05-14 Mitsubishi Kasei Corp 圧縮成型可能な粉体組成物
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
JPH09507867A (ja) * 1994-11-17 1997-08-12 バクスター、インターナショナル、インコーポレイテッド 血液透析におけるヘモグロビン療法
DE19535571A1 (de) 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
WO1998008537A1 (en) * 1996-08-27 1998-03-05 Hemosol Inc. Enhanced stimulation of erythropoiesis

Also Published As

Publication number Publication date
JP2007246530A (ja) 2007-09-27
BR9810267A (pt) 2000-09-12
DE59811768D1 (de) 2004-09-09
EP0996462B1 (de) 2004-08-04
KR20010014075A (ko) 2001-02-26
US6440932B1 (en) 2002-08-27
JP2002504913A (ja) 2002-02-12
KR100519904B1 (ko) 2005-10-10
ES2226151T3 (es) 2005-03-16
JP2011246474A (ja) 2011-12-08
US20050197281A1 (en) 2005-09-08
CA2294448A1 (en) 1998-12-30
AU743475B2 (en) 2002-01-24
EP0885613A1 (de) 1998-12-23
ATE272405T1 (de) 2004-08-15
DK0996462T3 (da) 2004-11-29
EP0996462A1 (de) 2000-05-03
PT996462E (pt) 2004-12-31
JP5785008B2 (ja) 2015-09-24
CN1185010C (zh) 2005-01-19
WO1998058660A1 (de) 1998-12-30
AU8109898A (en) 1999-01-04
CN1261282A (zh) 2000-07-26
CA2294448C (en) 2007-12-11
US20020160956A1 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
PT996462E (pt) Preparados de combinacoes farmaceuticas contendo eritropoietina e hemoglobinas modificadas
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
AU610636B2 (en) Stabilised human protein preparations
ES2139678T3 (es) Uso de eritropoyetina para la preparacion de una composicion farmaceutica para administracion pulmonar o inhalacion.
DK0582239T3 (da) Farmaceutisk og/eller kosmetisk formulering
ES2130428T3 (es) Cristales de insulina asp-b28.
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
ATE223204T1 (de) Liposomenzusammensetzung
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
FR2707638B1 (fr) Nouveaux dérivés d'amino-acides, leurs procédés de préparation et leur application thérapeutique.
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
IL85651A0 (en) Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them
EP0418065A3 (en) Dihydrocaffeic acid derivatives, use thereof for medical treatments and pharmaceutical preparations containing same
ATE45956T1 (de) 11 beta-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate.
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
TR199902305T2 (xx) Eritropoitein ve demir preperasyonları içeren farmasötik birleşimli preperasyonlar.